Regulus Therapeutics
  • ABOUT
  • TECHNOLOGY
    • Overview
    • Mechanism of Action
    • Pipeline
    • ADPKD
  • PATIENTS
  • INVESTORS
    • Overview
    • Press Releases
    • Events and Presentations
    • Financials & Filings
      • SEC Filings
      • Quarterly Results
    • Corporate Governance
      • Governance Documents
      • Board of Directors
      • Committee Composition
    • Analyst Coverage
    • Stock Information
      • Historical Stock Price
      • Investment Calculator
      • Insider Transactions
      • Fundamentals
      • Form 8937
    • Investor FAQs
    • Contact Us
  • CAREER

SEC Filings.

NASDAQRGLS
YearTrailing 12-MonthsCalendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014Calendar Year 2013Calendar Year 2012Calendar Year 2010
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Mergers & AcquisitionsProxy & Information StatementsOther
FormDescriptionDateFormat
4/AAmendment to a previously filed 4January 17, 2023Open Amendment to a previously filed 4 in HTML.Open Amendment to a previously filed 4 in DOC file.Open Amendment to a previously filed 4 in PDF file.Open Amendment to a previously filed 4 in XLS file.
4Statement of changes in beneficial ownership of securitiesJanuary 17, 2023Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
1-25      26-27

Copyright 2023 Regulus Therapeutics – All rights reserved

  • Terms and Conditions